稳定缺氧诱导因子1α恢复一氧化氮合酶1表达的表观遗传调控并逆转雌性糖尿病小鼠胃轻瘫
研究探讨缺氧诱导因子1α(HIF1A)是否为肠神经元中一氧化氮合酶1(Nos1)的转录因子,以及稳定HIF1A能否逆转胃轻瘫。在链脲佐菌素诱导的糖尿病小鼠中,HIF1A信号在糖尿病时降低,在表达Nos1的神经元中敲除Hif1a可使雌性而非雄性小鼠固体胃排空延迟,用罗沙司他稳定HIF1A可恢复NOS1并逆转雌性糖尿病小鼠的胃轻瘫。
要点
- HIF1A信号在小鼠和人NOS1+肌间神经元中活跃,但在糖尿病中降低。
- 在表达Nos1的神经元中敲除Hif1a使雌性而非雄性小鼠固体胃排空延迟。
- 罗沙司他稳定HIF1A可恢复NOS1并逆转雌性糖尿病小鼠的胃轻瘫。
核心结论
- 药理学稳定HIF1A是恢复氮能信号和治疗糖尿病胃轻瘫的一种新颖、可转化的方法。
研究设计与样本
- 研究使用链脲佐菌素诱导的糖尿病小鼠、人和小鼠组织、NOS1+小鼠神经母细胞瘤细胞及分离的氮能神经元。
- 固体胃排空和胃容积分别通过呼气试验和单光子发射计算机断层成像测定。
- 基因表达通过RNA测序、微阵列、免疫印迹和免疫荧光分析。
- 表观遗传学试验包括染色质免疫沉淀测序(13个靶点)、染色体构象捕获测序和报告基因试验。
- 机制研究使用Cre介导的重组、RNA干扰和CRISPR-Cas9介导的表观基因组编辑。
主要发现
- 在表达Nos1的神经元中敲除Hif1a使NOS1蛋白减少50%至92%,并使雌性而非雄性小鼠固体胃排空延迟。
- 用罗沙司他(FG-4592)稳定HIF1A可恢复NOS1并逆转雌性糖尿病小鼠的胃轻瘫。
- 在氮能神经元中,HIF1A通过结合并激活近端和远端顺式调控元件(包括新发现的超级增强子)上调Nos1转录,促进RNA聚合酶加载和暂停释放,并通过招募黏连蛋白至环锚点改变染色体拓扑结构。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Although depletion of neuronal nitric oxide synthase (NOS1)-expressing neurons contributes to gastroparesis, stimulating nitrergic signaling is not an effective therapy. We investigated whether hypoxia-inducible factor 1α (HIF1A), which is activated by high O2 consumption in central neurons, is a Nos1 transcription factor in enteric neurons and whether stabilizing HIF1A reverses gastroparesis. METHODS: Mice with streptozotocin-induced diabetes, human and mouse tissues, NOS1+ mouse neuroblastoma cells, and isolated nitrergic neurons were studied. Gastric emptying of solids and volumes were determined by breath test and single-photon emission computed tomography, respectively. Gene expression was analyzed by RNA-sequencing, microarrays, immunoblotting, and immunofluorescence. Epigenetic assays included chromatin immunoprecipitation sequencing (13 targets), chromosome conformation capture sequencing, and reporter assays. Mechanistic studies used Cre-mediated recombination, RNA interference, and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9)-mediated epigenome editing. RESULTS: HIF1A signaling from physiological intracellular hypoxia was active in mouse and human NOS1+ myenteric neurons but reduced in diabetes. Deleting Hif1a in Nos1-expressing neurons reduced NOS1 protein by 50% to 92% and delayed gastric emptying of solids in female but not male mice. Stabilizing HIF1A with roxadustat (FG-4592), which is approved for human use, restored NOS1 and reversed gastroparesis in female diabetic mice. In nitrergic neurons, HIF1A up-regulated Nos1 transcription by binding and activating proximal and distal cis-regulatory elements, including newly discovered super-enhancers, facilitating RNA polymerase loading and pause-release, and by recruiting cohesin to loop anchors to alter chromosome topology. CONCLUSIONS: Pharmacologic HIF1A stabilization is a novel, translatable approach to restoring nitrergic signaling and treating diabetic gastroparesis. The newly recognized effects of HIF1A on chromosome topology may provide insights into physioxia- and ischemia-related organ function.
引用
- Gao F, Hayashi Y, Saravanaperumal SA, et al. Hypoxia-Inducible Factor 1α Stabilization Restores Epigenetic Control of Nitric Oxide Synthase 1 Expression and Reverses Gastroparesis in Female Diabetic Mice. Gastroenterology. 2023. PMID: 37597632. doi:10.1053/j.gastro.2023.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。